Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
301.50    -0.50 (-0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £177.99m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Relationship Agreement and Board Appointment

20 Jan 2026 07:01

RNS Number : 5844P
Treatt PLC
20 January 2026
 

TREATT PLC

("Treatt" or "the Group")

Relationship Agreement with Döhler

and

Board appointment

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, announces that it has entered into a customary relationship agreement with major shareholder Döhler Finance Management B.V. and the appointment of Helga Moelschl as a Non-Executive Director of the Company.

Relationship Agreement

In light of its significant shareholding of 16,616,021 shares (representing approximately 28% of the issued share capital of the Company), Treatt entered into a customary relationship agreement with Döhler Finance Management B.V. ("Döhler") on 19 January 2026, which regulates the relationship between the Company and Döhler (the "Relationship Agreement").

In the Relationship Agreement, Döhler has undertaken, among other matters, to ensure that all transactions and arrangements between it and the Company will be conducted at arm's length and on normal commercial terms. Döhler has also agreed that it will not take any action or propose any shareholder resolution that would prevent the Company from complying with its obligations under the UK Listing Rules and other applicable regulatory requirements. The Relationship Agreement contains customary provisions governing the protection of confidential information by the Company with Döhler.

The Relationship Agreement also gives Döhler the right to nominate one candidate for appointment to the Board as a director of the Company for so long as the agreement is in effect, subject to prior consultation with the Board, the completion of customary due diligence and provided the relevant candidate fits the skills and experience profile required by the Board at the relevant time. 

The Relationship Agreement will terminate if Döhler's shareholding falls below 25 per cent. of the issued ordinary share capital of the Company.

Director appointment

Further to the entering into of the Relationship Agreement, Treatt announces that Helga Moelschl will join the Board as a Non-Executive Director on 1 February 2026. Helga's nomination was considered by the Company's Nomination Committee, which recognised Helga's significant industry experience.

Helga brings over 20 years' experience in the food ingredients and flavours industry and has held senior roles at leading companies in the sector, including IFF and Givaudan. During her career Helga has established a strong track record of business performance leadership, commercial excellence and sustainable value creation, underpinned by innovative consumer-centric strategies.

Helga was nominated by Döhler under the terms of the Relationship Agreement and she will consequently be classified as non-independent for the purpose of the UK Corporate Governance Code.

Treatt Chair, Vijay Thakrar said:

"The Board is committed to acting in the interests of all its shareholders. I am pleased to announce the Relationship Agreement with Döhler, which is both a significant shareholder and a highly respected company in the ingredients, life science and nutrition industry. After careful consideration, the Board concluded that it would be in the Company's best interest to enter into a suitable agreement with Döhler to regulate our relationship for the benefit of all shareholders and stakeholders of the Company. 

"I am also pleased to welcome Helga to the Board. Helga brings significant commercial experience of our industry from her time with IFF and Givaudan. I, and my Board colleagues, look forward to working with her."

There are no further matters to be disclosed pursuant to LR6.4.8R of the FCA's Listing Rules.

 

Treatt PLC (via MHP)

Vijay Thakrar Chair

Joint Brokers

Investec Bank Plc +44 (0) 20 7597 5970

David Anderson

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Financial PR

MHP + 44 (0) 7885 447 944

Tim Rowntree Treatt@mhpgroup.com

Eleni Menikou

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field. The Group employs approximately 350 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

For further information about the Group, visit www.treatt.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFFRLIIIFIR
Date   Source Headline
5th Jun 20263:25 pmRNSForm 8.3 - Treatt plc
5th Jun 20261:23 pmRNSForm 8.3 - Treatt plc
5th Jun 202612:57 pmRNSForm 8.3 TREATT PLC
5th Jun 202610:02 amRNSForm 8.3 Treatt Plc
4th Jun 20264:37 pmRNSHolding(s) in Company
4th Jun 20261:54 pmRNSForm 8.3 TREATT PLC
4th Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
4th Jun 202610:26 amRNSForm 8.3 Treatt plc
3rd Jun 20263:12 pmRNSForm 8.3 TREATT PLC
3rd Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
3rd Jun 202611:12 amRNSForm 8.3 Treatt Plc
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20262:59 pmRNSForm 8.3 TREATT PLC
2nd Jun 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
2nd Jun 202611:52 amRNSForm 8.3 Treatt plc
1st Jun 20263:20 pmRNSForm 8.3 TREATT PLC
1st Jun 20261:01 pmRNSBlock Listing Six Monthly Return
1st Jun 20261:00 pmRNSBlock Listing Six Monthly Return
1st Jun 202612:03 pmRNSForm 8.5 (EPT/RI) Treatt plc
1st Jun 202611:56 amRNSForm 8.3 Treatt Plc
29th May 20261:33 pmRNSForm 8.3 TREATT PLC
29th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
29th May 202611:30 amRNSForm 8.3 Treatt plc AXA IM UK
29th May 202611:17 amRNSForm 8.3 Treatt plc
29th May 202611:00 amRNS20260528_TREATT PLC_8.5 EPT RI_UK_MLI
28th May 20263:18 pmRNSForm 8.3 TREATT PLC
28th May 202612:17 pmRNSForm 8.3 - Treatt PLC
28th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
28th May 202611:22 amRNSForm 8.3 Treatt Plc
27th May 20261:54 pmRNSForm 8.3 TREATT PLC
27th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
27th May 202610:58 amRNS20260526_TREATT PLC_8.5 EPT RI_UK_MLI
26th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
26th May 202611:55 amRNSForm 8.3 Treatt plc
26th May 20268:20 amRNSForm 8.3 TREATT PLC
26th May 20267:00 amRNS20260522_TREATT PLC_8.5 EPT RI_UK_MLI
22nd May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
22nd May 202611:03 amRNSForm 8.3 TREATT PLC
22nd May 202610:34 amRNSForm 8.3 Treatt Plc
22nd May 202610:32 amRNSForm 8.3 Treatt Plc Replacement
21st May 20263:29 pmRNSForm 8.3 - Treatt PLC
21st May 20263:11 pmRNSForm 8.3 - TREATT PLC
21st May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
21st May 202611:41 amRNSForm 8.3 - Treatt plc
21st May 202611:09 amRNS20260520_TREATT PLC_8.5 EPT RI_UK_MLI
21st May 202611:01 amRNSForm 8.3 TREATT PLC
20th May 20263:25 pmRNSForm 8.3 - Treatt plc
20th May 20261:22 pmRNSForm 8.3 TREATT PLC
20th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
20th May 202611:38 amRNS20260519_TREATT PLC_8.5 EPT RI_UK_MLI

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.